6674:TSEGS Yuasa Corporation Analysis
Data as of 2026-06-22 - not real-time
NT$17.40
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at TWD 17.4, which sits below the 20‑day, 50‑day and 200‑day simple moving averages of 17.81, 18.11 and 19.95 respectively, signaling a sustained bearish bias. Momentum is neutral‑ish with an RSI of 45.4, while the MACD line remains under the signal line, producing a bearish histogram. Price is hugging the identified support level around 16.65 and is still below the resistance zone near 18.85, making the next move critical. Trading volume has been on a downward trend, and the 30‑day volatility is elevated at roughly 37.6%, indicating price swings could be sharp. A low beta of 0.21 suggests limited correlation with broader market moves, yet the max drawdown of -44.3% underscores historical pain.
Fundamentally, the company reports negative earnings with a trailing EPS of -1.13 and operating margins deep in the red at -56%, while free cash flow is also negative. The balance sheet shows modest cash of about TWD 279 million against relatively low debt, giving a debt‑to‑equity of 1.47. Valuation metrics such as a price‑to‑book of 1.31 appear reasonable against an industry PE average of 38.15, but the lack of earnings and a zero dividend make the stock more of a value play than a growth story. Market sentiment is currently in an “Extreme Greed” phase per the fear‑greed index, which may be overstating optimism despite the weak fundamentals.
Fundamentally, the company reports negative earnings with a trailing EPS of -1.13 and operating margins deep in the red at -56%, while free cash flow is also negative. The balance sheet shows modest cash of about TWD 279 million against relatively low debt, giving a debt‑to‑equity of 1.47. Valuation metrics such as a price‑to‑book of 1.31 appear reasonable against an industry PE average of 38.15, but the lack of earnings and a zero dividend make the stock more of a value play than a growth story. Market sentiment is currently in an “Extreme Greed” phase per the fear‑greed index, which may be overstating optimism despite the weak fundamentals.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and price below all major moving averages
- Decreasing volume and proximity to support level
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential bottoming near support with low beta exposure
- Reasonable price‑to‑book relative to assets
- Continued negative cash flow and earnings
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained negative profitability and margins
- Elevated historical drawdown and geopolitical exposure
- Lack of dividend and uncertain growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth-33.90%
Profit Margin-22.76%
ROE-13.66%
ROA-4.88%
Debt/Equity1.47
P/B Ratio1.3
Op. Cash FlowNT$-211846000
Free Cash FlowNT$-210888000
Industry P/E38.1
Technical Analysis
TrendBearish
RSI45.4
SupportNT$16.65
ResistanceNT$18.85
MA 20NT$17.81
MA 50NT$18.11
MA 200NT$19.95
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
GradeFair
TypeValue
Risk Assessment
Beta0.21
Volatility37.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.